Reaction Details Report a problem with these data
Target
Leukotriene C4 synthase
Ligand
BDBM223287
Substrate
n/a
Meas. Tech.
In Vitro hLTC4 Synthase Enzyme Assay
IC50
0.289±n/a nM
Citation
 Ronn, R; Lindh, CJ; Ringberg, E; Andersson, HB; Nilsson, P; Schaal, WR; Munck af Rosenschöld, M; Nikitidis, A; Nikitidis, G; Johannesson, P; Tyrchan, C Compounds and uses US Patent  US9657001 Publication Date 5/23/2017 
Target
Name:
Leukotriene C4 synthase
Synonyms:
LTC4 synthase | LTC4S | LTC4S_HUMAN | Leukotriene-C(4) synthase
Type:
PROTEIN
Mol. Mass.:
16575.59
Organism:
Homo sapiens (Human)
Description:
ChEMBL_961179
Residue:
150
Sequence:
MKDEVALLAAVTLLGVLLQAYFSLQVISARRAFRVSPPLTTGPPEFERVYRAQVNCSEYFPLFLATLWVAGIFFHEGAAALCGLVYLFARLRYFQGYARSAQLRLAPLYASARALWLLVALAALGLLAHFLPAALRAALLGRLRTLLPWA
  
Inhibitor
Name:
BDBM223287
Synonyms:
(1S,2S)-2-({5-[(5-Chloro-2,4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic acid | US20160326143, 62 | US9657001, 62
Type:
Small Organic Molecule
Emp. Form.:
C20H19ClF3N3O4
Mol. Mass.:
457.831
SMILES:
COc1nc(cnc1C(=O)[C@H]1C[C@@H]1C(O)=O)N(CC(C)(C)F)c1cc(Cl)c(F)cc1F
Structure:
Search PDB for entries with ligand similarity: